EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure

Sukhwinder K Bhullar, Naranjan S Dhalla iD

Canadian Journal of Physiology and Pharmacology · 01.02.2024 · 102 (2) · 86-104

DOI: 10.1139/cjpp-2023-0226 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Canadian Journal of Physiology and Pharmacology, erschienen am 01.02.2024. Verfasst von Sukhwinder K Bhullar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre and Department of Physiology and Pathophysiology, Max Rady Co…. Hauptthemen laut MEDLINE: Receptors, Angiotensin, Heart Failure. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 300 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiotensin II (Ang II) is formed by the action of angiotensin-converting enzyme (ACE) in the renin–angiotensin system. This hormone is known to induce cardiac hypertrophy and heart failure and its actions are mediated by the interaction of both pro- and antihypertrophic Ang II receptors (AT1R and AT2R). Ang II is also metabolized by ACE 2 to Ang-(1–7), which elicits the activation of Mas receptors (MasR) for inducing antihypertrophic actions. Since heart failure under different pathophysiological situations is preceded by adaptive and maladaptive cardiac hypertrophy, we have reviewed the existing literature to gain some information regarding the roles of AT1R, AT2R, and MasR in both acute and chronic conditions of cardiac hypertrophy. It appears that the activation of AT1R may be involved in the development of adaptive and maladaptive cardiac hypertrophy as well as subsequent heart failure because both ACE inhibitors and AT1R antagonists exert beneficial effects. On the other hand, the activation of both AT2R and MasR may prevent the occurrence of maladaptive cardiac hypertrophy and delay the progression of heart failure, and thus therapy with different activators of these antihypertrophic receptors under chronic pathological stages may prove beneficial. Accordingly, it is suggested that a great deal of effort should be made to develop appropriate activators of both AT2R and MasR for the treatment of heart failure subjects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, AngiotensinHeart FailureHumansRenin-Angiotensin SystemCardiomegalyAngiotensin IIReceptor, Angiotensin, Type 1

Stichwörter der Autor:innen

adaptive cardiac hypertrophyangiotensin IIangiotensin II receptorsheart failuremaladaptive cardiac hypertrophy

Substanzen

Receptors, AngiotensinAngiotensin IIReceptor, Angiotensin, Type 1

Autor:innen und Institutionen

  • Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre and Department of Physiology and Pathophysiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Canada.

ORCID-Profile: Naranjan S Dhalla

Zitieren

APA

Bhullar, S. K., & Dhalla, N. S. (2024). Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure. Canadian Journal of Physiology and Pharmacology, 102(2), 86-104. https://doi.org/10.1139/cjpp-2023-0226

Vancouver

Bhullar SK, Dhalla NS. Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure. Canadian Journal of Physiology and Pharmacology. 2024;102(2):86-104. doi:10.1139/cjpp-2023-0226

BibTeX
@article{Bhullar2024,
  author = {Bhullar, Sukhwinder K and Dhalla, Naranjan S},
  title = {Adaptive and maladaptive roles of different angiotensin receptors in the development of cardiac hypertrophy and heart failure},
  journal = {Canadian Journal of Physiology and Pharmacology},
  year = {2024},
  volume = {102},
  number = {2},
  pages = {86--104},
  doi = {10.1139/cjpp-2023-0226}
}
Kostenlos starten →